Fierce Pharma

NOVEMBER 2, 2023

The days of booming COVID-19 vaccine sales, which sent Moderna into the ranks of pharma's top companies, have | The company is focusing on scaling back its manufacturing efforts to cope with the lack of COVID-19 vaccine demand.

Manufacturing 300

Manufacturing Sales Pharma 300

Contrarian Sales Techniques

NOVEMBER 19, 2024

It’s a reality for many of us in pharma sales in Malaysia. Why This Hits Close to Home for Pharma Reps As someone in pharma sales, this problem feels personal. Pharma companies and sales reps often work together to raise awareness among doctors, pharmacists, and patients about how to spot fakes.”

Medicine 52

Medicine Sales Pharma Doctors 52

Fierce Pharma

MARCH 20, 2024

Sales came to 1.5 Four months ago, when BioNTech slashed its 2023 revenue projection from 5 billi | When BioNTech reported its fourth-quarter earnings Wednesday, it was another harsh reminder of the plummeting demand for COVID-19 vaccines. billion euros ($1.6 billion) for the fourth quarter and 3.8 billion euros ($4.1

Sales 331

Sales 331

Fierce Pharma

OCTOBER 16, 2023

The company now expects sales to reach between $58 billion and $61 billion, down from a prior range of $67 billion to $70 billion. Pfizer chalked up most of the decline to a $7 billion decrease in its projection for sales of oral antiviral Paxlovid.

Sales 360

Sales 360

Fierce Pharma

OCTOBER 15, 2024

In the complaints, GSK says it hopes to recover a “reasonable royalty” tied to Moderna’s vaccine sales, plus damages.

Sales 284

Sales 284

Fierce Pharma

OCTOBER 30, 2024

Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of expectations in the third quarter, leading the juggernaut company to reduce its annual revenue guidance and triggering speculat | Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of analyst expectations in the third quarter, leading the juggernaut company to reduce (..)

Sales 281

Sales Leads 281

Fierce Pharma

OCTOBER 31, 2024

In its second full quarter on the market, the fatty liver disease drug racked up sales of $62 million, which routed Wall Street's expectations and triggered a 16% surge in Madrigal's share price.

Sales 252

Sales Pharmaceutical Marketing 252

Fierce Pharma

FEBRUARY 1, 2024

As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023. Despite a sharp decline in COVID-related sales, the company was able to grow overall revenues | As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023.

Sales 226

Sales Pharma 226

Fierce Pharma

NOVEMBER 4, 2024

BioNTech reported surprisingly strong sales of its COVID-1 | BioNTech reported surprisingly strong sales of its COVID-19 vaccine in the third quarter. Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2.5 billion to €3.1

Sales 238

Sales 238

Fierce Pharma

APRIL 2, 2024

After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million deal | Merz Therapeutics, in a "stalking horse bid," agreed to pick up Acorda's Parkinson's disease med Inbrija and multiple sclerosis drug (..)

Sales 261

Sales Competition 261

Fierce Pharma

MAY 28, 2024

Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily

Pharma 199

Pharma Sales 199

Fierce Pharma

JANUARY 31, 2024

AstraZeneca-partnered Enhertu has become a bright spot in Daiichi Sankyo’s business, and the Japanese pharma has again increased its sales projection for the HER2-directed antibody-drug conjugate.<

Sales 203

Sales Pharma 203

Fierce Pharma

JANUARY 31, 2023

Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023. And Paxlovid won't fare much better kdunleavy Tue, 01/31/2023 - 10:58

Sales 334

Sales 334

Fierce Pharma

JUNE 12, 2023

Bayer recently laid out its ambition | Bayer recently laid out its ambition to achieve $10 billion in sales from its oncology business by 2030 and become a top 10 cancer drug player. To get there, the company is looking outside for a “midsize acquisition,” Bayer’s oncology chief Christine Roth said.

Sales goal 310

Sales goal Sales 310

Fierce Pharma

AUGUST 7, 2024

In the second quarter, Tepezza generated $479 million in sales for an increase of 8% year over year and 13% sequentially. It was Tepezza’s highest quarterly sales figure since Q4 of 2022. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable?

Sales 236

Sales Marketing 236

Fierce Pharma

JANUARY 9, 2023

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55.

Sales 315

Sales 315

Fierce Pharma

AUGUST 8, 2024

As Novavax presented its quarterly earnings, finance chief Jim Kelly said the company was “actively exploring” the sale of its manufacturing facility in the Czech Republic. It had a plan to become a COVID vaccine powerhouse, with enough manufacturing capacity to supply the U.S. |

Manufacturing 297

Manufacturing Sales Government 297

Fierce Pharma

JUNE 17, 2024

Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. |

Sales 270

Sales Marketing 270

Fierce Pharma

DECEMBER 13, 2024

Disgraced former OxyContin marketer Purdue Pharma is on the hook for billions after agreeing to settle cases that held the company responsible for fueling the U.S. Department of Justice, which was investigating the companys efforts to help Purdue increase its opioid sales. opioid crisis. In exchange, the DOJ will drop its charges.

Consulting 212

Consulting Pharma Sales Marketing 212

Contrarian Sales Techniques

NOVEMBER 21, 2024

For pharma sales reps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country. How Drug Access Programs Shape My Role As a pharma rep, I’ve seen the real, transformative impact of these programs. What Are Drug Access Programs?

Sales 52

Sales Pharma Medical Pharma sales reps 52

Fierce Pharma

MAY 6, 2024

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the next leg of its commercial journey. With plans to have at least 10 potentially registrational trials underway by the end of 2024, BioNTech is plotting the first wave of its market debut in oncology from 2026 onward.

Sales 295

Sales Marketing 295

Fierce Pharma

MAY 2, 2023

Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets kdunleavy Tue, 05/02/2023 - 09:27

Sales 299

Sales 299

Quantified

JANUARY 30, 2025

AI was novel in pharma training in early 2024. While these tools have their place, they dont fundamentally transform how sales teams learn, practice, and perform in the field. While these tools have their place, they dont fundamentally transform how sales teams learn, practice, and perform in the field. In 2025, its everywhere.

Training 52

Training Sales Pharma Medical science 52

Fierce Pharma

JANUARY 9, 2023

in COVID vaccine sales last year, projects at least $5B in 2023. JPM23: Moderna reaped $18.4B Mon, 01/09/2023 - 10:34.

Sales 307

Sales 307

Fierce Pharma

AUGUST 8, 2024

While a glut of drugmakers have raised their 2024 financial guidance after the second quarter, those upgraded sales expectations pale in comparison to Eli Lilly’s new forecast for the year. Lilly, which reported a 36% sales increase year-over-year to $11.3 All told, the company now expects to rake in sales between $45.5

Sales 251

Sales 251

Fierce Pharma

AUGUST 3, 2023

Even as Moderna chugs through another post-pandemic year, the biotech has raised its COVID-19 vaccine revenue projection in the expectation that it can deliver a strong showing in the private marke | The company raised its forecast for COVID-19 sales to between $6 billion and $8 billion, up from a prior estimate of $5 billion.

Sales 221

Sales Marketing Pharma 221

Fierce Pharma

APRIL 5, 2024

Despite Boehringer Ingelheim’s 2021 Humira biosimilar approval being heralded by some analysts as a “landmark achievement” for the field, the drug—dubbed Cyltezo—has struggled to gain traction than | Facing lackluster Cyltezo sales, Boehringer Ingelheim will prune its ranks in the U.S.

Sales 229

Sales Marketing 229

Close-Up CRM

JANUARY 21, 2025

These tools are not just modernizing sales execution but are redefining the art of customer engagement in ways previously unimaginable. The Role of AI in CRM: Transforming Pharma Sales AI in CRM is revolutionizing the way pharmaceutical companies interact with healthcare professionals (HCPs), patients, and other stakeholders.

CRM 52

CRM Sales Pharma Competition 52

Fierce Pharma

FEBRUARY 1, 2024

With Merck reporting a whopping $25 billion sales haul for | With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023. billion in 2022 and $55.1 billion in 2021.

Sales 278

Sales 278

Fierce Pharma

AUGUST 8, 2024

After taking a market share lead in the crowded Humira biosimilar space and with other key launches in the works, Novartis spinout Sandoz is raising its full-year sales guidance. | The company touts leading biosimilar market share for its version of AbbVie's Humira.

Sales 253

Sales Leads Marketing 253

Fierce Pharma

APRIL 26, 2024

AbbVie’s immunology heirs Skyrizi and Rinvoq are proving booming growth to make up for once-king Humira’s continuous sales slide. | As Humira continues its sales free fall, newer Skyrizi is proving a worthy successor with nearly matching sales ahead of an upcoming FDA decision in ulcerative colitis.

Sales 241

Sales FDA 241

Contrarian Sales Techniques

NOVEMBER 22, 2024

If you’re thinking about a career in medical sales for a local generic pharmaceutical company in Malaysia, you might already know it’s a fast-paced and competitive field. Here are 10 little-known facts about working as a medical sales rep in a local generic pharma company—and what you can expect from this dynamic and rewarding role.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Fierce Pharma

JULY 6, 2023

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga (..)

Sales 309

Sales Pharmaceutical 309

Fierce Pharma

OCTOBER 3, 2024

On the same day as Roche's Pharma Day in London, the biopharma giant revealed a high-dollar deal with Chinese-American biotech Regor for the latter's CDK inhibitors. |

Pharma 182

Pharma Biopharma Sales 182

Fierce Pharma

FEBRUARY 14, 2024

FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic fkansteiner Wed, 02/14/2024 - 05:10

Manufacturing 278

Manufacturing Sales FDA 278

pharmaphorum

NOVEMBER 12, 2024

AstraZeneca plans to invest a whopping $3.5

Biopharma 98

Biopharma Sales Manufacturing Pharma 98

Fierce Pharma

MAY 7, 2024

With Hyrimoz leading the way, sales of the company’s biosimilars reached $623 million in the first three months of this year. . | After spinning off as a separate business from Novartis, Sandoz is riding the wave of a strong launch of its biosimilar version of AbbVie’s Humira (adalimumab).

Leads 247

Leads Sales 247